1589932: BALOXAVIR MARBOXIL TABLET.
The BALOXAVIR MARBOXIL TABLET is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: BALOXAVIR MARBOXIL TABLET, 40MG, 2S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-693-3211, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | BALOXAVIR MARBOXIL TABLET, 40MG, 2S |
| NSN | 6505-01-693-3211 |
| SPECIAL FEATURES | IS A POLYMERASE ACIDIC (PA) ENDONUCLEASE INHIBITOR INDICATED FOR THE TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA IN PATIENTS 12 YEARS OF AGE AND OLDER; TAKE A SINGLE DOSE OF XOFLUZA ORALLY WITHIN 48 HOURS OF SYMPTOMS ONSET; AVOID CO-ADMINISTRATION WITH POLYVALENT CATION-CONTAINING LAXATIVES, ANTACIDS, OR ORAL SUPPLEMENTS; ONE ADULT DOSE OF TWO 40 MG TABLETS COME IN BLISTER PACK; STORE XOFLUZA IN ITS BLISTER PACKAGE AT 20 C TO 25 C (68 F TO 77 F); EXCURSIONS PERMITTED TO 15 C TO 30 C (59 F TO 86 F) (SEE USP CONTROLLED ROOM TEMPERATURE). |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | BALOXAVIR MARBOXIL TABLET, 40MG, 2S |